The aim of this study is to investigate the use of fullerene nanoparticles as an opportunistic adjuvant/delivery agent for synthetic peptide vaccine development and to test fullerene antioxidant activity in thyrocytes’ acquired from patients with autoimmune thyroiditis.
|Effective start/end date||1/05/19 → 31/03/20|
- Riga Stradins University: €20,000.00
- fullerene nanoparticles
Field of Science
- 3.1 Basic medicine
Smart Specialization Area
- Biomedicine, medical technologies and biotechnology
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.